Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

Article Abstract:

Mammalian heparanase is discussed relative to gene cloning, function and expression in tumor metastasis and progression. A 50-kDa heparanse from human hepatoma and placenta was purified. Cloning of the cDNA and gene encoding the enzyme is reported. The study discussed involved what is apparently the first cloned mammalian heparan sulfate (HS)-degrading enzyme and gives direct evidence of its role in tumor metastasis. Overexpression of the heparanse cDNA in low- or nonmetastatic tumor cells brought high metastatic potential in experimental mice.

Author: Pecker, Iris, Vlodavsky, Israel, Friedmann, Yael, Elkin, Michael, Aingorn, Helena, Atzmon, Ruth, Ishai-Michaeli, Rivka, Bitan, Menachem, Pappo, Orit, Peretz, Tuvia, Michal, Israel, Spector, Larissa
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Israel, Genetic aspects, Mice, Mice (Rodents), Cloning, Proteoglycans

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

Article Abstract:

Cloning of mammalian heparanase is discussed. It is an endoglycosidase important in tumor invasion and metastasis and important in the degradation of the extracellular matrix by invading cells, notably metastatic tumor cells and migrating leukocytes. The cDNA sequence of the human platelet enzyme is reported. Identification of highly homologous sequences in activated mouse T cells and in a highly metastatic rat adenocarcinoma has been carried out.

Author: Hulett, Mark D., Freeman, Craig, Hamdorf, Brenton J., Baker, Rohan T., Harris, Matthew J., Parish, Christpher R.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Australia, Cytochemistry, Rats, Extracellular matrix, Physiology, Glycosaminoglycans, Mucopolysaccharides

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Heparanase: Breaking down barriers in tumors

Article Abstract:

Heparanase, long-sought, has been cloned and characterized functionally adding to understanding and potential manipulation of metastasis and inflammatory processes. More is known about autoimmune conditions, as well. It has taken 20 years to isolate a heparanase gene, mainly because the enzymes are very unstable and it is difficult to design specific quantitative assays.

Author: Eccles, Suzanne A.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
United States

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Statistical Data Included, Usage, Physiological aspects, Metastasis, Cancer metastasis, Mammals, Tumors, Heparin, Research, Enzymes
Similar abstracts:
  • Abstracts: Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis
  • Abstracts: Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. Adenosine-induced atrial arrhythmia: a prospective analysis
  • Abstracts: Hydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line
  • Abstracts: Respiratory diseases and allergies in two polluted areas in East Germany. The effect of ambient carbon monoxide on low birth weight among children born in Southern California between 1989 and 1993
  • Abstracts: A case-crossover analysis of air pollution and mortality in Philadelphia. Episodes of high coarse particle concentration are not associated with increased mortality
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.